Paramedir is developing innovative biomonitoring solutions based on biosensors and microfluidics. The first product in development is an in-vitro diagnostic (IVD) that can continuously assess kidney function in an intensive care setting.Member of the management team and co-owner. Responsible for strategy development, business development, partnering, and funding.

Member of the management team and leading the international marketing & sales team at eLabNext.Responsible for global marketing, branding, sales and business development. Key results:- Achieved strong revenue growth year-over-year- Succesfully led a strategic rebranding project- Set up an international sales organization and reporting structure- Build effective international sales and marketing teams

Coaching start-ups in life sciences & health. (part-time)

Diagnoptics is the pioneer of cutting edge diagnostic devices that enable clinicians to non-invasively assess cardiovascular risk and diabetes risk. Its flagship product is the AGE Reader – a state of art non-invasive medical device that provides a cardiovascular risk assessment within 12 seconds.Member of the management team- Responsible for marketing & sales plans and budgets.- International business development.- Developing new marketing materials and website.-… Show more Diagnoptics is the pioneer of cutting edge diagnostic devices that enable clinicians to non-invasively assess cardiovascular risk and diabetes risk. Its flagship product is the AGE Reader – a state of art non-invasive medical device that provides a cardiovascular risk assessment within 12 seconds.Member of the management team- Responsible for marketing & sales plans and budgets.- International business development.- Developing new marketing materials and website.- Establishing and supporting an international network of distributors.- New product development and market introduction.- Maintaining contact with end-users and Key Opinion Leaders.- Keeping track of developments in medical markets. Show less

- Marketing and sales of DiagnOptics' innovative medical devices.- Developing new marketing materials and website.- Involved in obtaining international regulatory approval.- New product development and market introduction.- Establishing and improving the Quality Management System.

Commercialisation of knowledge and technology in the life sciences: intellectual property management, licensing and setting-up spin-out companies.Categories: - biomarkers & drug development- biomaterials & tissue engineering- biotechnology- medical devices- medical services and treatment.

Effectiveness analysis of the subsidy policy of the Dutch Diabetes Research Foundation.